ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
10
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,825
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Author(s):
Markus Knuf
,
Geert Leroux-Roels
,
Hans Rümke
,
Katia Abarca
,
Luis Rivera
,
Maria Lattanzi
,
Paola Pedotti
,
Ashwani Arora
,
Dorothee Kieninger-Baum
,
Giovanni Della Cioppa
Publication date:
2015
Journal:
Vaccine
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via OAI-PMH doi match)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Malaria vaccine development
Author and article information
Journal
DOI::
10.1016/j.vaccine.2014.10.085
PubMed ID::
25444803
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,825
In vitro assessment of the allergenicity of novel MF59-adjuvanted pandemic H1N1 influenza vaccine produced in dog kidney cells
Authors:
Ramon Bencharitiwong
,
Stephanie Y. Leonard
,
Theodore F Tsai
…
MF59 es un adyuvante para vacunas seguro y potente que potencia la protección frente a la infección por el virus de la gripe
Authors:
D. O'Hagan
,
D. T. O’Hagan
A phase I/II Trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
Authors:
S Nitayaphan
See all similar
Cited by
10
AS03- and MF59-Adjuvanted Influenza Vaccines in Children
Authors:
Amanda L. Wilkins
,
Dmitri Kazmin
,
Giorgio Napolitani
…
Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen
Authors:
Alex Salyer
,
Giuseppe Caruso
,
Karishma K. Khetani
…
Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?
Authors:
Claudia Trombetta
,
Simona Piccirella
,
Daniele Perini
…
See all cited by
Version 1
- Current
Version 1